The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review

go back to reference Allyse M et al (2015) Non-invasive prenatal testing: a review of international implementation and challenges. Int J Women's Health 113. https://doi.org/10.2147/IJWH.S67124 Allyse M et al (2015) Non-invasive prenatal testing: a review of international implementation and challenges. Int J Women's Health 113. https://​doi.​org/​10.​2147/​IJWH.​S67124

go back to reference Aravanis AM, Lee M, Klausner RD (2017) Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell 168:571–574PubMedCrossRef Aravanis AM, Lee M, Klausner RD (2017) Next-generation sequencing of circulating tumor DNA for early cancer detection. Cell 168:571–574PubMedCrossRef

go back to reference Badalian-Very G, Vergilio JA, Degar BA, MacConaill L, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919–1923PubMedPubMedCentralCrossRef Badalian-Very G, Vergilio JA, Degar BA, MacConaill L, Brandner B, Calicchio ML, Kuo FC, Ligon AH, Stevenson KE, Kehoe SM, Garraway LA, Hahn WC, Meyerson M, Fleming MD, Rollins BJ (2010) Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood 116:1919–1923PubMedPubMedCentralCrossRef

go back to reference Barris DM et al (2018) Detection of circulating tumor DNA in patients with osteosarcoma. Oncotarget 9 Barris DM et al (2018) Detection of circulating tumor DNA in patients with osteosarcoma. Oncotarget 9

go back to reference Berry J et al (2017) Aqueous humor as a surrogate liquid tumor biopsy in retinoblastoma. ISOO 2017, Abstract 0028 Berry J et al (2017) Aqueous humor as a surrogate liquid tumor biopsy in retinoblastoma. ISOO 2017, Abstract 0028

go back to reference Berry JL et al (2018) Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: the surrogate tumor biopsy for retinoblastoma. Mol Cancer Res. https://doi.org/10.1158/1541-7786.MCR-18-0369 PubMedCrossRef Berry JL et al (2018) Genomic cfDNA analysis of aqueous humor in retinoblastoma predicts eye salvage: the surrogate tumor biopsy for retinoblastoma. Mol Cancer Res. https://​doi.​org/​10.​1158/​1541-7786.​MCR-18-0369 PubMedCrossRef

go back to reference Bettegowda C et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra24PubMedPubMedCentralCrossRef Bettegowda C et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra24PubMedPubMedCentralCrossRef

go back to reference Bhatnagar S (2009) Management of Wilms’ tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg 14:6–14PubMedPubMedCentralCrossRef Bhatnagar S (2009) Management of Wilms’ tumor: NWTS vs SIOP. J Indian Assoc Pediatr Surg 14:6–14PubMedPubMedCentralCrossRef

go back to reference Bruscaggin A et al (2017) Genotyping of classical Hodgkin lymphoma on the liquid biopsy. Hematol Oncol 35:64–65CrossRef Bruscaggin A et al (2017) Genotyping of classical Hodgkin lymphoma on the liquid biopsy. Hematol Oncol 35:64–65CrossRef

go back to reference Burnham P et al (2018) Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat Commun 9:2412PubMedPubMedCentralCrossRef Burnham P et al (2018) Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat Commun 9:2412PubMedPubMedCentralCrossRef

go back to reference Campana D (2010) Minimal residual disease in acute lymphoblastic leukemia. Hematology 2010:7–12PubMedCrossRef Campana D (2010) Minimal residual disease in acute lymphoblastic leukemia. Hematology 2010:7–12PubMedCrossRef

go back to reference Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474PubMedPubMedCentralCrossRef Capper D, Jones DTW, Sill M, Hovestadt V, Schrimpf D, Sturm D, Koelsche C, Sahm F, Chavez L, Reuss DE, Kratz A, Wefers AK, Huang K, Pajtler KW, Schweizer L, Stichel D, Olar A, Engel NW, Lindenberg K, Harter PN, Braczynski AK, Plate KH, Dohmen H, Garvalov BK, Coras R, Hölsken A, Hewer E, Bewerunge-Hudler M, Schick M, Fischer R, Beschorner R, Schittenhelm J, Staszewski O, Wani K, Varlet P, Pages M, Temming P, Lohmann D, Selt F, Witt H, Milde T, Witt O, Aronica E, Giangaspero F, Rushing E, Scheurlen W, Geisenberger C, Rodriguez FJ, Becker A, Preusser M, Haberler C, Bjerkvig R, Cryan J, Farrell M, Deckert M, Hench J, Frank S, Serrano J, Kannan K, Tsirigos A, Brück W, Hofer S, Brehmer S, Seiz-Rosenhagen M, Hänggi D, Hans V, Rozsnoki S, Hansford JR, Kohlhof P, Kristensen BW, Lechner M, Lopes B, Mawrin C, Ketter R, Kulozik A, Khatib Z, Heppner F, Koch A, Jouvet A, Keohane C, Mühleisen H, Mueller W, Pohl U, Prinz M, Benner A, Zapatka M, Gottardo NG, Driever PH, Kramm CM, Müller HL, Rutkowski S, von Hoff K, Frühwald MC, Gnekow A, Fleischhack G, Tippelt S, Calaminus G, Monoranu CM, Perry A, Jones C, Jacques TS, Radlwimmer B, Gessi M, Pietsch T, Schramm J, Schackert G, Westphal M, Reifenberger G, Wesseling P, Weller M, Collins VP, Blümcke I, Bendszus M, Debus J, Huang A, Jabado N, Northcott PA, Paulus W, Gajjar A, Robinson GW, Taylor MD, Jaunmuktane Z, Ryzhova M, Platten M, Unterberg A, Wick W, Karajannis MA, Mittelbronn M, Acker T, Hartmann C, Aldape K, Schüller U, Buslei R, Lichter P, Kool M, Herold-Mende C, Ellison DW, Hasselblatt M, Snuderl M, Brandner S, Korshunov A, von Deimling A, Pfister SM (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474PubMedPubMedCentralCrossRef

go back to reference Chen T et al (2016) Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types. BMC Genomics 17:394PubMedPubMedCentralCrossRef Chen T et al (2016) Hotspot mutations delineating diverse mutational signatures and biological utilities across cancer types. BMC Genomics 17:394PubMedPubMedCentralCrossRef

go back to reference Chicard M, Boyault S, Colmet Daage L, Richer W, Gentien D, Pierron G, Lapouble E, Bellini A, Clement N, Iacono I, Bréjon S, Carrere M, Reyes C, Hocking T, Bernard V, Peuchmaur M, Corradini N, Faure-Conter C, Coze C, Plantaz D, Defachelles AS, Thebaud E, Gambart M, Millot F, Valteau-Couanet D, Michon J, Puisieux A, Delattre O, Combaret V, Schleiermacher G (2016) Genomic copy number profiling using circulating free tumor DNA highlights heterogeneity in neuroblastoma. Clin Cancer Res 22:5564–5573PubMedCrossRef Chicard M, Boyault S, Colmet Daage L, Richer W, Gentien D, Pierron G, Lapouble E, Bellini A, Clement N, Iacono I, Bréjon S, Carrere M, Reyes C, Hocking T, Bernard V, Peuchmaur M, Corradini N, Faure-Conter C, Coze C, Plantaz D, Defachelles AS, Thebaud E, Gambart M, Millot F, Valteau-Couanet D, Michon J, Puisieux A, Delattre O, Combaret V, Schleiermacher G (2016) Genomic copy number profiling using circulating free tumor DNA highlights heterogeneity in neuroblastoma. Clin Cancer Res 22:5564–5573PubMedCrossRef

go back to reference Chicard M et al (2017) Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma. Clin Cancer Res 1586. https://doi.org/10.1158/1078-0432.CCR-17-1586 PubMedCrossRef Chicard M et al (2017) Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma. Clin Cancer Res 1586. https://​doi.​org/​10.​1158/​1078-0432.​CCR-17-1586 PubMedCrossRef

go back to reference Clementi A, Virzì GM, Brocca A, Pastori S, de Cal M, Marcante S, Granata A, Ronco C (2016) The role of cell-free plasma DNA in critically ill patients with sepsis. Blood Purif 41:34–40PubMedCrossRef Clementi A, Virzì GM, Brocca A, Pastori S, de Cal M, Marcante S, Granata A, Ronco C (2016) The role of cell-free plasma DNA in critically ill patients with sepsis. Blood Purif 41:34–40PubMedCrossRef

go back to reference Combaret V et al (2002) Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res 62:3646–3648PubMed Combaret V et al (2002) Circulating MYCN DNA as a tumor-specific marker in neuroblastoma patients. Cancer Res 62:3646–3648PubMed

go back to reference Combaret V et al (2015) Detection of tumor ALK status in neuroblastoma patients using peripheral blood. Cancer Med 4:540–550PubMedPubMedCentralCrossRef Combaret V et al (2015) Detection of tumor ALK status in neuroblastoma patients using peripheral blood. Cancer Med 4:540–550PubMedPubMedCentralCrossRef

go back to reference Corrias MV et al (2018) Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Pediatr Blood Cancer 65:e27052PubMedCrossRef Corrias MV et al (2018) Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis. Pediatr Blood Cancer 65:e27052PubMedCrossRef

go back to reference Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Suñol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J, Stegmaier K (2014) The genomic landscape of pediatric Ewing sarcoma. Cancer Discov 4:1326–1341PubMedCrossRef Crompton BD, Stewart C, Taylor-Weiner A, Alexe G, Kurek KC, Calicchio ML, Kiezun A, Carter SL, Shukla SA, Mehta SS, Thorner AR, de Torres C, Lavarino C, Suñol M, McKenna A, Sivachenko A, Cibulskis K, Lawrence MS, Stojanov P, Rosenberg M, Ambrogio L, Auclair D, Seepo S, Blumenstiel B, DeFelice M, Imaz-Rosshandler I, Schwarz-Cruz Y Celis A, Rivera MN, Rodriguez-Galindo C, Fleming MD, Golub TR, Getz G, Mora J, Stegmaier K (2014) The genomic landscape of pediatric Ewing sarcoma. Cancer Discov 4:1326–1341PubMedCrossRef

go back to reference De Koker A, Van Paemel R, De Wilde B, De Preter K, Callewaert N (2019) A versatile method for circulating cell-free DNA methylome profiling by reduced representation bisulfite sequencing. bioRxiv 663195. https://doi.org/10.1101/663195 De Koker A, Van Paemel R, De Wilde B, De Preter K, Callewaert N (2019) A versatile method for circulating cell-free DNA methylome profiling by reduced representation bisulfite sequencing. bioRxiv 663195. https://​doi.​org/​10.​1101/​663195

go back to reference De Mattos-Arruda L et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839PubMedPubMedCentralCrossRef De Mattos-Arruda L et al (2015) Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma. Nat Commun 6:8839PubMedPubMedCentralCrossRef

go back to reference De Vlaminck I et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6:241ra77PubMedPubMedCentralCrossRef De Vlaminck I et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6:241ra77PubMedPubMedCentralCrossRef

go back to reference El Messaoudi S, Rolet F, Mouliere F, Thierry AR (2013) Circulating cell free DNA: Preanalytical considerations. Clin Chim Acta 424:222–230PubMedCrossRef El Messaoudi S, Rolet F, Mouliere F, Thierry AR (2013) Circulating cell free DNA: Preanalytical considerations. Clin Chim Acta 424:222–230PubMedCrossRef

go back to reference Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald N, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892PubMedPubMedCentralCrossRef Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald N, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883–892PubMedPubMedCentralCrossRef

go back to reference Gielis EM, Ledeganck KJ, de Winter BY, del Favero J, Bosmans JL, Claas FH, Abramowicz D, Eikmans M (2015) Cell-free DNA: an upcoming biomarker in transplantation. Am J Transplant 15:2541–2551PubMedCrossRef Gielis EM, Ledeganck KJ, de Winter BY, del Favero J, Bosmans JL, Claas FH, Abramowicz D, Eikmans M (2015) Cell-free DNA: an upcoming biomarker in transplantation. Am J Transplant 15:2541–2551PubMedCrossRef

go back to reference Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17:333–351PubMedCrossRef Goodwin S, McPherson JD, McCombie WR (2016) Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet 17:333–351PubMedCrossRef

go back to reference Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, ICGC PedBrain-Seq Project, ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg C, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM (2018) The landscape of genomic alterations across childhood cancers. Nature 555:321–327PubMedCrossRef Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, Bender S, Hutter B, Sturm D, Pfaff E, Hübschmann D, Zipprich G, Heinold M, Eils J, Lawerenz C, Erkek S, Lambo S, Waszak S, Blattmann C, Borkhardt A, Kuhlen M, Eggert A, Fulda S, Gessler M, Wegert J, Kappler R, Baumhoer D, Burdach S, Kirschner-Schwabe R, Kontny U, Kulozik AE, Lohmann D, Hettmer S, Eckert C, Bielack S, Nathrath M, Niemeyer C, Richter GH, Schulte J, Siebert R, Westermann F, Molenaar JJ, Vassal G, Witt H, ICGC PedBrain-Seq Project, ICGC MMML-Seq Project, Burkhardt B, Kratz CP, Witt O, van Tilburg C, Kramm CM, Fleischhack G, Dirksen U, Rutkowski S, Frühwald M, von Hoff K, Wolf S, Klingebiel T, Koscielniak E, Landgraf P, Koster J, Resnick AC, Zhang J, Liu Y, Zhou X, Waanders AJ, Zwijnenburg DA, Raman P, Brors B, Weber UD, Northcott PA, Pajtler KW, Kool M, Piro RM, Korbel JO, Schlesner M, Eils R, Jones DTW, Lichter P, Chavez L, Zapatka M, Pfister SM (2018) The landscape of genomic alterations across childhood cancers. Nature 555:321–327PubMedCrossRef

go back to reference Hartomo TB et al (2013) Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells. Oncol Rep 29:1629–1636PubMedCrossRef Hartomo TB et al (2013) Minimal residual disease monitoring in neuroblastoma patients based on the expression of a set of real-time RT-PCR markers in tumor-initiating cells. Oncol Rep 29:1629–1636PubMedCrossRef

go back to reference Hayashi M, Chu D, Meyer CF, Llosa NJ, McCarty G, Morris CD, Levin AS, Wolinsky JP, Albert CM, Steppan DA, Park BH, Loeb DM (2016) Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. Cancer 122:3015–3023PubMedCrossRef Hayashi M, Chu D, Meyer CF, Llosa NJ, McCarty G, Morris CD, Levin AS, Wolinsky JP, Albert CM, Steppan DA, Park BH, Loeb DM (2016) Highly personalized detection of minimal Ewing sarcoma disease burden from plasma tumor DNA. Cancer 122:3015–3023PubMedCrossRef

go back to reference Huang TY et al (2017) Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28PubMedPubMedCentralCrossRef Huang TY et al (2017) Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma. Acta Neuropathol Commun 5:28PubMedPubMedCentralCrossRef

go back to reference Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541–1552CrossRefPubMed Hunger SP, Mullighan CG (2015) Acute lymphoblastic leukemia in children. N Engl J Med 373:1541–1552CrossRefPubMed

go back to reference Jiménez I et al (2018) Circulating tumor DNA analysis enables molecular characterisation of pediatric renal tumors at diagnosis. Int J Cancer. https://doi.org/10.1002/ijc.31620 PubMedCrossRef Jiménez I et al (2018) Circulating tumor DNA analysis enables molecular characterisation of pediatric renal tumors at diagnosis. Int J Cancer. https://​doi.​org/​10.​1002/​ijc.​31620 PubMedCrossRef

go back to reference Jonkman-Berk BM, van den Berg J, ten Berge I, Bredius RG, Driessen GJ, Dalm VA, van Dissel J, van Deuren M, Ellerbroek PM, van der Flier M, van Hagen P, van Montfrans J, Rutgers A, Schölvinck EH, de Vries E, van Beem R, Kuijpers TW (2015) Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy. Clin Immunol 156:154–162PubMedCrossRef Jonkman-Berk BM, van den Berg J, ten Berge I, Bredius RG, Driessen GJ, Dalm VA, van Dissel J, van Deuren M, Ellerbroek PM, van der Flier M, van Hagen P, van Montfrans J, Rutgers A, Schölvinck EH, de Vries E, van Beem R, Kuijpers TW (2015) Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy. Clin Immunol 156:154–162PubMedCrossRef

go back to reference Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M (2016) Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clin Biochem 49:1354–1360PubMedCrossRef Kang Q, Henry NL, Paoletti C, Jiang H, Vats P, Chinnaiyan AM, Hayes DF, Merajver SD, Rae JM, Tewari M (2016) Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes. Clin Biochem 49:1354–1360PubMedCrossRef

go back to reference Klega K et al (2018) Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors. JCO Precis Oncol:1–13. https://doi.org/10.1200/PO.17.00285 Klega K et al (2018) Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors. JCO Precis Oncol:1–13. https://​doi.​org/​10.​1200/​PO.​17.​00285

go back to reference Krumbholz M et al (2016) Genomic EWSR1 fusion sequence as highly sensitive and dynamic plasma tumor marker in Ewing sarcoma. Clin Cancer Res 22:4356–4365PubMedCrossRef Krumbholz M et al (2016) Genomic EWSR1 fusion sequence as highly sensitive and dynamic plasma tumor marker in Ewing sarcoma. Clin Cancer Res 22:4356–4365PubMedCrossRef

go back to reference Kurihara S, Ueda Y, Onitake Y, Sueda T, Ohta E, Morihara N, Hirano S, Irisuna F, Hiyama E (2015) Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors. J Pediatr Surg 50:2094–2097PubMedCrossRef Kurihara S, Ueda Y, Onitake Y, Sueda T, Ohta E, Morihara N, Hirano S, Irisuna F, Hiyama E (2015) Circulating free DNA as non-invasive diagnostic biomarker for childhood solid tumors. J Pediatr Surg 50:2094–2097PubMedCrossRef

go back to reference Lammens CRM et al (2010) Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits. Familial Cancer 9:647–654PubMedPubMedCentralCrossRef Lammens CRM et al (2010) Regular surveillance for Li-fraumeni syndrome: advice, adherence and perceived benefits. Familial Cancer 9:647–654PubMedPubMedCentralCrossRef

go back to reference Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646–650PubMed Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37:646–650PubMed

go back to reference Lodrini M et al (2017) Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget. https://doi.org/10.18632/oncotarget.19076 PubMedPubMedCentralCrossRef Lodrini M et al (2017) Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma. Oncotarget. https://​doi.​org/​10.​18632/​oncotarget.​19076 PubMedPubMedCentralCrossRef

go back to reference Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820PubMedCrossRef Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820PubMedCrossRef

go back to reference Machado ASC et al (2010) Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma 51:1020–1027PubMedCrossRef Machado ASC et al (2010) Circulating cell-free and Epstein–Barr virus DNA in pediatric B-non-Hodgkin lymphomas. Leuk Lymphoma 51:1020–1027PubMedCrossRef

go back to reference Martínez-Ricarte F et al (2018) Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-3800 PubMedCrossRef Martínez-Ricarte F et al (2018) Molecular diagnosis of diffuse gliomas through sequencing of cell-free circulating tumor DNA from cerebrospinal fluid. Clin Cancer Res. https://​doi.​org/​10.​1158/​1078-0432.​CCR-17-3800 PubMedCrossRef

go back to reference Medina Diaz I et al (2016) Performance of Streck cfDNA blood collection tubes for liquid biopsy testing. PLoS One 11:e0166354PubMedPubMedCentralCrossRef Medina Diaz I et al (2016) Performance of Streck cfDNA blood collection tubes for liquid biopsy testing. PLoS One 11:e0166354PubMedPubMedCentralCrossRef

go back to reference Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C, Hsieh WY, Selcuklu SD, Ling L, Meng F, Jing X, Samoila A, Bale TA, Tsui DWY, Grommes C, Viale A, Souweidane MM, Tabar V, Brennan CW, Reiner AS, Rosenblum M, Panageas KS, DeAngelis L, Young RJ, Berger MF, Mellinghoff IK (2019) Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654–658PubMedPubMedCentralCrossRef Miller AM, Shah RH, Pentsova EI, Pourmaleki M, Briggs S, Distefano N, Zheng Y, Skakodub A, Mehta SA, Campos C, Hsieh WY, Selcuklu SD, Ling L, Meng F, Jing X, Samoila A, Bale TA, Tsui DWY, Grommes C, Viale A, Souweidane MM, Tabar V, Brennan CW, Reiner AS, Rosenblum M, Panageas KS, DeAngelis L, Young RJ, Berger MF, Mellinghoff IK (2019) Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid. Nature 565:654–658PubMedPubMedCentralCrossRef

go back to reference Moss J et al (2018) Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun 9:5068PubMedPubMedCentralCrossRef Moss J et al (2018) Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun 9:5068PubMedPubMedCentralCrossRef

go back to reference Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials. JAMA 291:2720PubMedCrossRef Murthy VH, Krumholz HM, Gross CP (2004) Participation in cancer clinical trials. JAMA 291:2720PubMedCrossRef

go back to reference Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A (2013) Plasma cell-free DNA in paediatric lymphomas. J Cancer 4:323–329PubMedPubMedCentralCrossRef Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A (2013) Plasma cell-free DNA in paediatric lymphomas. J Cancer 4:323–329PubMedPubMedCentralCrossRef

go back to reference Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23:1136–1148PubMedPubMedCentralCrossRef Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23:1136–1148PubMedPubMedCentralCrossRef

go back to reference Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasugi N (1997) Mass screening for neuroblastoma and mortality in birth cohorts. Int J Cancer 71:552–555PubMedCrossRef Nishi M, Miyake H, Takeda T, Hanai J, Kikuchi Y, Takasugi N (1997) Mass screening for neuroblastoma and mortality in birth cohorts. Int J Cancer 71:552–555PubMedCrossRef

go back to reference Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743PubMedPubMedCentralCrossRef Pajtler KW, Witt H, Sill M, Jones DT, Hovestadt V, Kratochwil F, Wani K, Tatevossian R, Punchihewa C, Johann P, Reimand J, Warnatz HJ, Ryzhova M, Mack S, Ramaswamy V, Capper D, Schweizer L, Sieber L, Wittmann A, Huang Z, van Sluis P, Volckmann R, Koster J, Versteeg R, Fults D, Toledano H, Avigad S, Hoffman LM, Donson AM, Foreman N, Hewer E, Zitterbart K, Gilbert M, Armstrong TS, Gupta N, Allen JC, Karajannis MA, Zagzag D, Hasselblatt M, Kulozik AE, Witt O, Collins VP, von Hoff K, Rutkowski S, Pietsch T, Bader G, Yaspo ML, von Deimling A, Lichter P, Taylor MD, Gilbertson R, Ellison DW, Aldape K, Korshunov A, Kool M, Pfister SM (2015) Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743PubMedPubMedCentralCrossRef

go back to reference Paret C et al (2017) Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. Oncotarget 8 Paret C et al (2017) Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy. Oncotarget 8

go back to reference Poulsen MLM, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49–59PubMedCrossRef Poulsen MLM, Budtz-Jørgensen E, Bisgaard ML (2010) Surveillance in von Hippel-Lindau disease (vHL). Clin Genet 77:49–59PubMedCrossRef

go back to reference Primerano S, Burnelli R, Carraro E, Pillon M, Elia C, Farruggia P, Sala A, Vinti L, Buffardi S, Basso G, Mascarin M, Mussolin L (2016) Kinetics of circulating plasma cell-free dna in paediatric classical Hodgkin lymphoma. J Cancer 7:364–366PubMedPubMedCentralCrossRef Primerano S, Burnelli R, Carraro E, Pillon M, Elia C, Farruggia P, Sala A, Vinti L, Buffardi S, Basso G, Mascarin M, Mussolin L (2016) Kinetics of circulating plasma cell-free dna in paediatric classical Hodgkin lymphoma. J Cancer 7:364–366PubMedPubMedCentralCrossRef

go back to reference Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM (2013) The genetic landscape of high-risk neuroblastoma. Nat Genet 45:279–284PubMedPubMedCentralCrossRef Pugh TJ, Morozova O, Attiyeh EF, Asgharzadeh S, Wei JS, Auclair D, Carter SL, Cibulskis K, Hanna M, Kiezun A, Kim J, Lawrence MS, Lichenstein L, McKenna A, Pedamallu CS, Ramos AH, Shefler E, Sivachenko A, Sougnez C, Stewart C, Ally A, Birol I, Chiu R, Corbett RD, Hirst M, Jackman SD, Kamoh B, Khodabakshi AH, Krzywinski M, Lo A, Moore RA, Mungall KL, Qian J, Tam A, Thiessen N, Zhao Y, Cole KA, Diamond M, Diskin SJ, Mosse YP, Wood AC, Ji L, Sposto R, Badgett T, London WB, Moyer Y, Gastier-Foster JM, Smith MA, Guidry Auvil JM, Gerhard DS, Hogarty MD, Jones SJ, Lander ES, Gabriel SB, Getz G, Seeger RC, Khan J, Marra MA, Meyerson M, Maris JM (2013) The genetic landscape of high-risk neuroblastoma. Nat Genet 45:279–284PubMedPubMedCentralCrossRef

go back to reference Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047–1053PubMedCrossRef Schilling FH, Spix C, Berthold F, Erttmann R, Fehse N, Hero B, Klein G, Sander J, Schwarz K, Treuner J, Zorn U, Michaelis J (2002) Neuroblastoma screening at one year of age. N Engl J Med 346:1047–1053PubMedCrossRef

go back to reference Seoane J, De Mattos-Arruda L, Le Rhun E, Bardelli A, Weller M (2019) Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases. Ann Oncol 30:211–218PubMedCrossRef Seoane J, De Mattos-Arruda L, Le Rhun E, Bardelli A, Weller M (2019) Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases. Ann Oncol 30:211–218PubMedCrossRef

go back to reference Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M, McPherson J, O'Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman SV, Hung RJ, de Carvalho DD (2018) Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563:579–583PubMedCrossRef Shen SY, Singhania R, Fehringer G, Chakravarthy A, Roehrl MHA, Chadwick D, Zuzarte PC, Borgida A, Wang TT, Li T, Kis O, Zhao Z, Spreafico A, Medina TDS, Wang Y, Roulois D, Ettayebi I, Chen Z, Chow S, Murphy T, Arruda A, O'Kane GM, Liu J, Mansour M, McPherson J, O'Brien C, Leighl N, Bedard PL, Fleshner N, Liu G, Minden MD, Gallinger S, Goldenberg A, Pugh TJ, Hoffman MM, Bratman SV, Hung RJ, de Carvalho DD (2018) Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature 563:579–583PubMedCrossRef

go back to reference Shukla NN et al (2017) Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive Sarcomas. JCO Precis Oncol:1–11. https://doi.org/10.1200/PO.16.00028 Shukla NN et al (2017) Plasma DNA-based molecular diagnosis, prognostication, and monitoring of patients with EWSR1 fusion-positive Sarcomas. JCO Precis Oncol:1–11. https://​doi.​org/​10.​1200/​PO.​16.​00028

go back to reference Siravegna G, Marsoni S, Siena S, Bardelli A (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. https://doi.org/10.1038/nrclinonc.2017.14 PubMedCrossRef Siravegna G, Marsoni S, Siena S, Bardelli A (2017) Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. https://​doi.​org/​10.​1038/​nrclinonc.​2017.​14 PubMedCrossRef

go back to reference Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren A, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072PubMedPubMedCentralCrossRef Sturm D, Orr BA, Toprak UH, Hovestadt V, Jones DTW, Capper D, Sill M, Buchhalter I, Northcott PA, Leis I, Ryzhova M, Koelsche C, Pfaff E, Allen SJ, Balasubramanian G, Worst BC, Pajtler KW, Brabetz S, Johann PD, Sahm F, Reimand J, Mackay A, Carvalho DM, Remke M, Phillips JJ, Perry A, Cowdrey C, Drissi R, Fouladi M, Giangaspero F, Łastowska M, Grajkowska W, Scheurlen W, Pietsch T, Hagel C, Gojo J, Lötsch D, Berger W, Slavc I, Haberler C, Jouvet A, Holm S, Hofer S, Prinz M, Keohane C, Fried I, Mawrin C, Scheie D, Mobley BC, Schniederjan MJ, Santi M, Buccoliero AM, Dahiya S, Kramm CM, von Bueren A, von Hoff K, Rutkowski S, Herold-Mende C, Frühwald MC, Milde T, Hasselblatt M, Wesseling P, Rößler J, Schüller U, Ebinger M, Schittenhelm J, Frank S, Grobholz R, Vajtai I, Hans V, Schneppenheim R, Zitterbart K, Collins VP, Aronica E, Varlet P, Puget S, Dufour C, Grill J, Figarella-Branger D, Wolter M, Schuhmann MU, Shalaby T, Grotzer M, van Meter T, Monoranu CM, Felsberg J, Reifenberger G, Snuderl M, Forrester LA, Koster J, Versteeg R, Volckmann R, van Sluis P, Wolf S, Mikkelsen T, Gajjar A, Aldape K, Moore AS, Taylor MD, Jones C, Jabado N, Karajannis MA, Eils R, Schlesner M, Lichter P, von Deimling A, Pfister SM, Ellison DW, Korshunov A, Kool M (2016) New brain tumor entities emerge from molecular classification of CNS-PNETs. Cell 164:1060–1072PubMedPubMedCentralCrossRef

go back to reference Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel M, Berthold F, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2009) Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clin Chem 55:1316–1326PubMedCrossRef Stutterheim J, Gerritsen A, Zappeij-Kannegieter L, Yalcin B, Dee R, van Noesel M, Berthold F, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2009) Detecting minimal residual disease in neuroblastoma: the superiority of a panel of real-time quantitative PCR markers. Clin Chem 55:1316–1326PubMedCrossRef

go back to reference Stutterheim J, Zappeij-Kannegieter L, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2011) The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma. Eur J Cancer 47:1193–1202PubMedCrossRef Stutterheim J, Zappeij-Kannegieter L, Versteeg R, Caron HN, van der Schoot C, Tytgat GA (2011) The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastoma. Eur J Cancer 47:1193–1202PubMedCrossRef

go back to reference Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugières L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23:e32–e37PubMedCrossRef Tabori U, Hansford JR, Achatz MI, Kratz CP, Plon SE, Frebourg T, Brugières L (2017) Clinical management and tumor surveillance recommendations of inherited mismatch repair deficiency in childhood. Clin Cancer Res 23:e32–e37PubMedCrossRef

go back to reference Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M (2016) Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 35:347–376PubMedPubMedCentralCrossRef Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M (2016) Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev 35:347–376PubMedPubMedCentralCrossRef

go back to reference Ueno-Yokohata H et al (2018) Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA. Genes Chromosom Cancer. https://doi.org/10.1002/gcc.22648 PubMedCrossRef Ueno-Yokohata H et al (2018) Preoperative diagnosis of clear cell sarcoma of the kidney by detection of BCOR internal tandem duplication in circulating tumor DNA. Genes Chromosom Cancer. https://​doi.​org/​10.​1002/​gcc.​22648 PubMedCrossRef

go back to reference Van Roy N et al (2017) Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-17-0675 PubMedCrossRef Van Roy N et al (2017) Shallow whole genome sequencing on circulating cell-free DNA allows reliable noninvasive copy-number profiling in neuroblastoma patients. Clin Cancer Res. https://​doi.​org/​10.​1158/​1078-0432.​CCR-17-0675 PubMedCrossRef

go back to reference Van Wezel EM et al (2015) Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma. J Mol Diagn 17:43–52PubMedCrossRef Van Wezel EM et al (2015) Whole-genome sequencing identifies patient-specific DNA minimal residual disease markers in neuroblastoma. J Mol Diagn 17:43–52PubMedCrossRef

go back to reference van Wezel EM et al (2016) Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. Eur J Cancer 54:149–158PubMedCrossRef van Wezel EM et al (2016) Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients. Eur J Cancer 54:149–158PubMedCrossRef

go back to reference Viprey VF, Corrias MV, Kagedal B, Oltra S, Swerts K, Vicha A, Ladenstein R, Burchill SA (2007) Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 43:341–350PubMedCrossRef Viprey VF, Corrias MV, Kagedal B, Oltra S, Swerts K, Vicha A, Ladenstein R, Burchill SA (2007) Standardisation of operating procedures for the detection of minimal disease by QRT-PCR in children with neuroblastoma: Quality assurance on behalf of SIOPEN-R-NET. Eur J Cancer 43:341–350PubMedCrossRef

go back to reference Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA (2014) Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study. J Clin Oncol 32:1074–1083PubMedCrossRef Viprey VF, Gregory WM, Corrias MV, Tchirkov A, Swerts K, Vicha A, Dallorso S, Brock P, Luksch R, Valteau-Couanet D, Papadakis V, Laureys G, Pearson AD, Ladenstein R, Burchill SA (2014) Neuroblastoma mRNAs predict outcome in children with stage 4 neuroblastoma: a European HR-NBL1/SIOPEN study. J Clin Oncol 32:1074–1083PubMedCrossRef

go back to reference Wan JCM et al (2016) Liquid biopsies come of age: clinical applications of circulating tumour DNA. Nat Rev Cancer. https://doi.org/10.1038/nrc.2017.7 PubMedCrossRef Wan JCM et al (2016) Liquid biopsies come of age: clinical applications of circulating tumour DNA. Nat Rev Cancer. https://​doi.​org/​10.​1038/​nrc.​2017.​7 PubMedCrossRef

go back to reference Weaver KD, Grossman SA, Herman JG (2006) Methylated tumor-specific DNA as a plasma biomarker in patients with Glioma. Cancer Investig 24:35–40CrossRef Weaver KD, Grossman SA, Herman JG (2006) Methylated tumor-specific DNA as a plasma biomarker in patients with Glioma. Cancer Investig 24:35–40CrossRef

go back to reference Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, Gerdes AM, Goldberg Y, Ilencikova D, Muleris M, Duval A, Lavoine N, Ruiz-Ponte C, Slavc I, Burkhardt B, Brugieres L, EU-Consortium Care for CMMRD (C4CMMRD) (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365PubMedCrossRef Wimmer K, Kratz CP, Vasen HF, Caron O, Colas C, Entz-Werle N, Gerdes AM, Goldberg Y, Ilencikova D, Muleris M, Duval A, Lavoine N, Ruiz-Ponte C, Slavc I, Burkhardt B, Brugieres L, EU-Consortium Care for CMMRD (C4CMMRD) (2014) Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD). J Med Genet 51:355–365PubMedCrossRef

go back to reference Woods WG et al (2002) Screening of infants and mortality due to neuroblastoma. N Engl J Med 346:1041–1046PubMedCrossRef Woods WG et al (2002) Screening of infants and mortality due to neuroblastoma. N Engl J Med 346:1041–1046PubMedCrossRef

go back to reference Worst BC, van Tilburg C, Balasubramanian GP, Fiesel P, Witt R, Freitag A, Boudalil M, Previti C, Wolf S, Schmidt S, Chotewutmontri S, Bewerunge-Hudler M, Schick M, Schlesner M, Hutter B, Taylor L, Borst T, Sutter C, Bartram CR, Milde T, Pfaff E, Kulozik AE, von Stackelberg A, Meisel R, Borkhardt A, Reinhardt D, Klusmann JH, Fleischhack G, Tippelt S, Dirksen U, Jürgens H, Kramm CM, von Bueren A, Westermann F, Fischer M, Burkhardt B, Wößmann W, Nathrath M, Bielack SS, Frühwald MC, Fulda S, Klingebiel T, Koscielniak E, Schwab M, Tremmel R, Driever PH, Schulte JH, Brors B, von Deimling A, Lichter P, Eggert A, Capper D, Pfister SM, Jones DT, Witt O (2016) Next-generation personalised medicine for high-risk paediatric cancer patients - the INFORM pilot study. Eur J Cancer 65:91–101PubMedCrossRef Worst BC, van Tilburg C, Balasubramanian GP, Fiesel P, Witt R, Freitag A, Boudalil M, Previti C, Wolf S, Schmidt S, Chotewutmontri S, Bewerunge-Hudler M, Schick M, Schlesner M, Hutter B, Taylor L, Borst T, Sutter C, Bartram CR, Milde T, Pfaff E, Kulozik AE, von Stackelberg A, Meisel R, Borkhardt A, Reinhardt D, Klusmann JH, Fleischhack G, Tippelt S, Dirksen U, Jürgens H, Kramm CM, von Bueren A, Westermann F, Fischer M, Burkhardt B, Wößmann W, Nathrath M, Bielack SS, Frühwald MC, Fulda S, Klingebiel T, Koscielniak E, Schwab M, Tremmel R, Driever PH, Schulte JH, Brors B, von Deimling A, Lichter P, Eggert A, Capper D, Pfister SM, Jones DT, Witt O (2016) Next-generation personalised medicine for high-risk paediatric cancer patients - the INFORM pilot study. Eur J Cancer 65:91–101PubMedCrossRef

go back to reference Yáñez Y, Hervás D, Grau E, Oltra S, Pérez G, Palanca S, Bermúdez M, Márquez C, Cañete A, Castel V (2016) TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients. J Cancer Res Clin Oncol 142:573–580PubMedCrossRef Yáñez Y, Hervás D, Grau E, Oltra S, Pérez G, Palanca S, Bermúdez M, Márquez C, Cañete A, Castel V (2016) TH and DCX mRNAs in peripheral blood and bone marrow predict outcome in metastatic neuroblastoma patients. J Cancer Res Clin Oncol 142:573–580PubMedCrossRef